FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Takeshi Ichikawa

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Livers

Procedures

Disorders

Co-author Network

Publications

TOP 3
Tatsuya Ohyama; Yuichi Yamazaki; Ken Sato; Norio Horiguchi; Takeshi Ichikawa; Satoru Kakizaki; Hitoshi Takagi; Masatomo Mori
Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1.
Hideyuki Suzuki; Satoru Kakizaki; Norio Horiguchi; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Masatomo Mori
Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C.
Satoru Kakizaki; Mitsuo Toyoda; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Hirotaka Arai; Naondo Sohara; Haruhisa Iizuka; Yasuhiro Onozato; Masatomo Mori
Clinical characteristics and treatment for patients presenting with bleeding duodenal varices.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Takeshi Ichikawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Tatsuya Ohyama; Yuichi Yamazaki; Ken Sato; Norio Horiguchi; Takeshi Ichikawa; Satoru Kakizaki; Hitoshi Takagi; Masatomo Mori
Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1.
Liver international : official journal of the International Association for the Study of the Liver 2011;31(4):572-84.
2010: Hideyuki Suzuki; Satoru Kakizaki; Norio Horiguchi; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Masatomo Mori
Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C.
World journal of hepatology 2010;2(11):401-5.
2010: Satoru Kakizaki; Mitsuo Toyoda; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Hirotaka Arai; Naondo Sohara; Haruhisa Iizuka; Yasuhiro Onozato; Masatomo Mori
Clinical characteristics and treatment for patients presenting with bleeding duodenal varices.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 2010;22(4):275-81.
2010: Daichi Takizawa; Satoru Kakizaki; Norio Horiguchi; Hiroki Tojima; Yuichi Yamazaki; Takeshi Ichikawa; Ken Sato; Masatomo Mori
Histone deacetylase inhibitors induce cytochrome P450 2B by activating nuclear receptor constitutive androstane receptor.
Drug metabolism and disposition: the biological fate of chemicals 2010;38(9):1493-8.
2009: Takeshi Ichikawa; Hitoshi Takagi; Masatomo Mori
Abdominal tuberculosis in the absence of pulmonary involvement shown by 2-[fluorine 18] fluoro-2-deoxy-D-glucose positron emission tomography.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(12):A20.
2009: Hideyuki Suzuki; Mitsuo Toyoda; Norio Horiguchi; Satoru Kakizaki; Tatsuya Ohyama; Daichi Takizawa; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Masatomo Mori
Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
Liver international : official journal of the International Association for the Study of the Liver 2009;29(10):1562-8.
2009: Satoru Kakizaki; Hideyuki Suzuki; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Masatomo Mori; Keiichiro Yuasa
[A case of autoimmune hepatitis which worsened after switching from a brand name to a generic version of prednisolone].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 2009;106(10):1488-93.
2009: Katsuhiko Horiuchi; Satoru Kakizaki; Takashi Kosone; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Masatomo Mori; Shinji Sakurai; Toshio Fukusato
Marked eosinophilia as the first manifestation of sclerosing cholangitis.
Internal medicine (Tokyo, Japan) 2009;48(16):1377-82.
2008: Takeshi Ichikawa; Hiroko Sato; Kyoichi Kaira; Shinsuke Oh-I; Satoru Kakizaki; Ken Sato; Hitoshi Takagi; Masatomo Mori
Prolonged intrahepatic cholestasis after exposure to loxoprofen.
Clinical therapeutics 2008;30(12):2402-6.
2008: Ken Sato; Hitoshi Takagi; Takeshi Ichikawa; Satoru Kakizaki; Masatomo Mori
Emerging therapeutic strategies for hepatitis C virus infection.
Current molecular pharmacology 2008;1(2):130-50.
2008: Yuichi Yamazaki; Satoru Kakizaki; Daichi Takizawa; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Masatomo Mori
Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
Journal of gastroenterology and hepatology 2008;23(2):276-82.
2008: Satoru Kakizaki; Daichi Takizawa; Yuichi Yamazaki; Yuka Nakajima; Takeshi Ichikawa; Ken Sato; Hitoshi Takagi; Masatomo Mori; Kazunori Kasama
Nonalcoholic fatty liver disease in Japanese patients with severe obesity who received laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) in comparison to non-Japanese patients.
Journal of gastroenterology 2008;43(1):86-92.
2008: Satoshi Hagiwara; Toshiyuki Otsuka; Yuichi Yamazaki; Takashi Kosone; Naondo Sohara; Takeshi Ichikawa; Ken Sato; Satoru Kakizaki; Hitoshi Takagi; Masatomo Mori
Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(1):126-31.
2005: Ryuya Shimoda; K Horiuchi; S Hagiwara; H Suzuki; Yuichi Yamazaki; Takashi Kosone; Takeshi Ichikawa; Hirotaka Arai; Tatsuya Yamada; Takehiko Abe; Hitoshi Takagi; Masatomo Mori
Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts.
Abdominal imaging 2005;30(3):306-13.
2002: Daisuke Kanda; Hitoshi Takagi; Yoshiaki Hashimoto; Yuichi Yamazaki; Masayuki Matsui; Takashi Kosone; Hirotaka Arai; Takeshi Ichikawa; Hiroaki Nakajima; Toshiyuki Otsuka; Akira Kojima; Ken Sato; Satoru Kakizaki; Yutaka Matsuzaki; Tatsuhiko Matsumoto; Ryuya Shimoda; Mieko Kaneko; Hisashi Takayama; Hitomi Takahashi; Takehiko Abe; Jiro Takezawa; Masatomo Mori
Severe manifestation of acute hepatitis A recently found in Gunma, Japan.
Journal of gastroenterology 2002;37(7):517-22.
2000: Satoru Kakizaki; Hitoshi Takagi; Takeshi Ichikawa; Takehiko Abe; Tatsuya Yamada; Kazuhiro Suzuki; Akira Kojima; Hisashi Takayama; Jiro Takezawa; Takeaki Nagamine; Masatomo Mori
Histological change after interferon therapy in chronic hepatitis C in view of iron deposition in the liver.
Biological trace element research 2000;73(2):151-62.
1999: Hitoshi Takagi; Satoru Kakizaki; K Satoh; Mitsuo Toyoda; Norio Horiguchi; Hisashi Takayama; Daisuke Kanda; Hiroaki Nakajima; Takeshi Ichikawa; Akira Kojima; Yutaka Matsuzaki; Ryuya Shimoda; Tatsuhiko Matsumoto; Mieko Kaneko; Yoshiaki Hashimoto; Takehiko Abe; Takeaki Nagamine; Masatomo Mori
Prevalence of hepatitis G virus in liver disease.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 1999;13(10):823-6.
1999: Satoru Kakizaki; Hitoshi Takagi; Tatsuya Yamada; Takeshi Ichikawa; Takehiko Abe; Naondo Sohara; Takashi Kosone; Mieko Kaneko; Jiro Takezawa; Hisashi Takayama; Takeaki Nagamine; Masatomo Mori
Evaluation of twice-daily administration of interferon-beta for chronic hepatitis C.
Journal of viral hepatitis 1999;6(4):315-9.
1998: Takeshi Ichikawa; Hitoshi Takagi; M Kinoshita; Ryuya Shimoda; Takeaki Nagamine; Masatomo Mori
Quantitative analysis of hepatitis B virus precore mutant in hepatitis type B.
The Tohoku journal of experimental medicine 1998;186(4):323-33.